BOCKORNY GROUP, INC. for ABBOTT LABORATORIES
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Implementation of the Patient Protection and Affordable Health Care Act H.R. 3497 - Moddern Cures Act of 2011 H.R. 5651- Food and Drug Administration Reform Act of 2012 S. 3187 Food and Drug Administration Safety and Innovation Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID BOCKORNY | — |
| MELISSA SCHULMAN | — |
| PAUL SCOTT SHEARER | — |
| NICOLE VENABLE | — |
Food Industry (safety, labeling, etc.) FOO
Issues relating to infant formula
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA SCHULMAN | — |
| PAUL SCOTT SHEARER | — |
| NICOLE VENABLE | — |
Taxation/Internal Revenue Code TAX
Corporate Tax Reform Proposals Deferral US Taxes on Foreign Income
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID BOCKORNY | — |
| MELISSA SCHULMAN | — |
| PAUL SCOTT SHEARER | — |
| NICOLE VENABLE | — |
Medicare/Medicaid MMM
Medicare Part D drug benefit
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID BOCKORNY | — |
| MELISSA SCHULMAN | — |
| PAUL SCOTT SHEARER | — |
| NICOLE VENABLE | — |
Trade (domestic/foreign) TRD
Global health and development U.S. Negotiations on Trans Pacific Partnership S. 3285, A bill to authorize the extension of nondiscriminatory treatment (normal trade relations treatment) to products of the Russian Federation. H.R. 4405, Sergei Magnitsky Rule of Law Accountability Act of 2012 S. 1039, Sergei Magnitsky Rule of Law Accountability Act of 2011
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICOLE VENABLE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.